AltheaDx

About:

AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.

Website: http://altheadx.com

Twitter/X: altheadx

Top Investors: WuXi Healthcare Ventures, Telegraph Hill Partners

Description:

AltheaDx, Inc. provides molecular diagnostics and PCR-based services. It offers molecular biomarker discovery, assay development, assay validation, and prospective/retrospective clinical trial testing services. The company also provides gene expression and genotyping analysis for pre-clinical and clinical applications. In addition, it offers discovery services, such as microarray analysis, real-time PCR, next-gen sequencing, quantitative PCR, mutation scanning, data analysis, race assay, and therapeutic siRNA; and diagnostic development services.

Total Funding Amount:

$83.4M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Contact Email:

sales(AT)altheadx.com

Founders:

Magda Marquet

Number of Employees:

101-250

Last Funding Date:

2020-09-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai